GYN Publications

  • Buza N, Hui P. Gestational trophoblastic disease: histopathological diagnosis in the molecular era. Diagnostic Histopathology 2010 Nov; 16(11):526-537. Hui P. Molecular Diagnosis of Gestational Trophoblastic Disease (Invited review). Expert Review of Molecular Diagnostics 2010, 10:1023-1034. Cytology and Surgical Pathology of Gynecologic Neoplasms, First Edition, ed. 
  • Chhieng D and Hui P. Springer, 2011, ISBN 978-1-60761-163-9. Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology. First Edition, ed. Hui P. Springer, 2012, ISBN: 978-1-61779-393-6.
  • Buza N, Hui P. New diagnostic modalities in the histopathological diagnosis of hydatidiform moles. Diagnostic Histopathology. 2012;18 (5):201-209. 
  • Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD. HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas. International Journal of Gynecological Pathology. 2012; 31(3):211-21. 
  • Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Landscape of Somatic Single Nucleotide and Copy Number Mutations in Uterine Serous Carcinoma. Proceedings of National Academy of Sciences USA, 2013, 110(8):2916-21. 
  • Buza N, Hui P. Partial Hydatidiform Mole: Histological Parameters in Correlation with DNA Genotyping. International Journal of Gynecological Pathology 2013, 32(3): 307-15. Buza N, English DP, Santin AD, Hui P. Toward Standard HER2 Testing of Endometrial Serous Carcinoma: Four-Year Experience At A Large Academic Center and Recommendations for Clinical Practice. Modern Pathology 2013 Jun 14. doi: 10.1038/modpathol.2013.113. [Epub ahead of print] 
  • Buza N, Hui P. Marked Heterogeneity of HER2/NEU Gene Amplification in Endometrial Serous Carcinoma. Genes Chromosomes Cancer. 2013 Oct 7. doi: 10.1002/gcc.22113. [Epub ahead of print] 
  • Alomari A, Abi-Raad R, Buza N., Hui P. Frequent KRAS Mutation in Complex Mucinous Epithelial Lesions of the Endometrium. Modern Pathology 2013 Nov 1. doi: 10.1038/modpathol.2013.186. [Epub ahead of print] Buza N, Rutherford T, Hui P. Genotyping Diagnosis of Non-gestational Choriocarcinoma involving fallopian tube and broad ligament: a Case Study. International Journal of Gynecological Pathology, 2013, in press. 
  • Buza N, Hui P. Egg donor pregnancy: A potential pitfall in DNA genotyping diagnosis of hydatidiform moles. International Journal of Gynecological Pathology, 2013, in press. Abi-Raad R, Alomari A, Hui P, Buza N. Mitotically Active Microglandular Hyperplasia Of The Cervix: A Case Series With Implications For The Differential Diagnosis. International Journal of Gynecological Pathology, 2013, in press.

Recent Abstracts from Meetings

  • Natalia Buza, Pei Hui. Diagnosis of Partial Hydatidiform Mole: Histological Reassessment in Correlation with DNA Genotyping. USCAP 2012. 
  • Natalia Buza, Diana English, Alessandro D. Santin and Pei Hui. HER2 Testing In Endometrial Carcinoma: Four-Year Experience At A Large Tertiary Academic Center. USCAP 2013.
  • Rita Abi-Raad, Ahmed Alomari, Pei Hui and Natalia Buza. Mitotically active microglandular hyperplasia of the cervix: absence of K-Ras mutation and implications for differential diagnosis. USCAP 2013. 
  • Ryan J. Carr, Pei Hui, Natalia Buza. Clinicopathologic Characteristics of Intravenous leiomyomatosis: An Experience of 12 Cases at a Single Medical Center. USCAP 2013. Melissa Much, Natalia Buza, Pei Hui. Tissue Identity Testing of Cancer by Short Tandem Repeat Polymorphism: Pitfalls Of Interpretation in the Presence of Microsatellite Instability. USCAP 2013. 
  • Ahmed Alomari, Rita Abi-Raad, Natalia Buza, Pei Hui. Correlation of K-Ras Mutation with Histological Subtypes of Endometrial Mucinous Lesions: Implications for Biological Progression and Molecular Diagnosis. USCAP 2013. 
  • Dana M. Roque, Natalia Buza, Michelle Glasgow, Elena Ratner, Dan Arin-Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Alessandro D. Santin. Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel. SGO 2013 Agedi Boto, Pei Hui, Natalia Buza. Overexpression of Tubulin β-3 in Endometrial Carcinomas. USCAP 2104 Sudhir Perincheri.
  • Natalia Buza, Pei Hui. Tissue Identity Testing by STR Genotyping: An Eight-Year Experience at a Single Tertiary Medical Center. USCAP 2014.